AviSia Therapeutics

Amsterdam, Netherlands · Founded 2024 · Privately Held (backing)

Developer of antigen-specific immunotherapies intended to treat autoimmune diseases. AviSia Therapeutics is based in Amsterdam, Netherlands and was founded in 2024. It has raised $410,000.

Last price · $/share
—
Implied valuation
—
Total raised
$410K
Last round
—

Who backs AviSia Therapeutics?

1 investors
InvestorType
Innovatiefonds Noord-HollandVenture capital
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

AviSia Therapeutics investors

1 investor is on record for AviSia Therapeutics, including Innovatiefonds Noord-Holland. By type, the record holds 1 venture capital firm.

Free account
More of AviSia Therapeutics with a free account
  • ·Watch AviSia Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 1 firms already write checks for companies like AviSia Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View